Global Presence Expansion TCG Lifesciences has established a strong international footprint with operations in the United States, Europe, and Japan, demonstrating its ability to support global pharmaceutical and biotech companies in diverse markets.

Robust R&D Capabilities With over 1,300 scientists including more than 300 PhDs, TCG Lifesciences offers a comprehensive suite of services across chemistry, pharmacology, analytical development, and data science, making it a versatile partner for companies seeking innovative research solutions.

Focused Therapeutic Expertise The company specializes in key therapeutic areas such as Inflammation & Pain, Infectious Diseases, Central Nervous System, and Oncology, presenting opportunities to collaborate with clients targeting high-priority market segments.

Strategic Industry Collaborations Recent partnerships, such as with SOA for chemical and biological sciences research, highlight TCG's ability to engage in strategic alliances, opening avenues for co-development projects and joint ventures.

Financial and Infrastructure Strength With revenues between $25M and $50M, advanced infrastructure including cGMP laboratories, FDA accreditation, and specialized animal facilities, TCG Lifesciences is well-positioned to handle large-scale, high-quality development projects for pharma and biotech clients.